EUA for B. Braun’s Propofol-lipuro
Federal Register notice: FDA has announced for administrative purposes the issuance of an emergency use authorization to B. Braun Melsungen AG and the use of its sedative propofol-lipuro 1% injectable emulsion in Covid-19 patients requiring mechanical ventilation. To view the notice, click here.